ATE112573T1 - Inhibin und dessen reinigung. - Google Patents

Inhibin und dessen reinigung.

Info

Publication number
ATE112573T1
ATE112573T1 AT86904699T AT86904699T ATE112573T1 AT E112573 T1 ATE112573 T1 AT E112573T1 AT 86904699 T AT86904699 T AT 86904699T AT 86904699 T AT86904699 T AT 86904699T AT E112573 T1 ATE112573 T1 AT E112573T1
Authority
AT
Austria
Prior art keywords
leu
pro
cys
phe
gly
Prior art date
Application number
AT86904699T
Other languages
English (en)
Inventor
Nicholas Chai-Kwan Ling
Shao-Yao Ying
Fred Stephen Esch
Roger Charles Louis Guillemin
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE112573T1 publication Critical patent/ATE112573T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT86904699T 1985-07-18 1986-07-17 Inhibin und dessen reinigung. ATE112573T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75686685A 1985-07-18 1985-07-18
US06/784,436 US4740587A (en) 1985-07-18 1985-10-03 Inhibin and method of purifying same

Publications (1)

Publication Number Publication Date
ATE112573T1 true ATE112573T1 (de) 1994-10-15

Family

ID=27116303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86904699T ATE112573T1 (de) 1985-07-18 1986-07-17 Inhibin und dessen reinigung.

Country Status (7)

Country Link
US (1) US4740587A (de)
EP (1) EP0232326B1 (de)
JP (1) JPH07108916B2 (de)
AT (1) ATE112573T1 (de)
AU (1) AU605105B2 (de)
DE (1) DE3650088T2 (de)
WO (1) WO1987000528A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
DE3650689T2 (de) 1985-04-18 1999-04-08 Biotechnology Australia Pty. Ltd., East Roseville, Neussuedwales Rekombinantes inhibin
AU610821B2 (en) * 1985-04-18 1991-05-30 Inhibin Pty Limited Recombinant inhibin
JPH0637520B2 (ja) * 1985-07-03 1994-05-18 味の素株式会社 ポリペプチド
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
ZA867569B (en) * 1985-10-03 1988-06-29 Genentech Inc Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid
US5047336A (en) * 1985-10-30 1991-09-10 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides
US5427780A (en) * 1985-10-30 1995-06-27 Biogen, Inc. Composition comprising Mullerian inhibiting substance-like polypeptides
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
ZA871844B (en) * 1986-03-13 1988-05-25 Biotechnology Pty Ltd Method of assay of inhibin
US5015729A (en) * 1986-06-24 1991-05-14 The Salk Institute For Biological Studies Ovine inhibin
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
JP2653125B2 (ja) * 1988-09-22 1997-09-10 味の素株式会社 血糖低下剤
US5200395A (en) * 1988-10-18 1993-04-06 Ajinomoto Company, Inc. Pharmaceutical composition of BUF-5 for treating anemia
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
DK0698094T3 (da) * 1993-05-12 2004-05-03 Inst Genetics Llc BMP-11-sammensætninger
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
DE69434651T2 (de) 1993-12-07 2007-03-08 Genetics Institute, Inc., Cambridge Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US5658876A (en) * 1994-04-28 1997-08-19 The General Hospital Corporation Activin antagonists as novel contraceptives
JPH07238097A (ja) * 1994-09-07 1995-09-12 Masao Igarashi インヒビンを抗原とするIgG抗体
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
ATE271886T1 (de) 1999-10-15 2004-08-15 Inst Genetics Llc Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
WO2002099037A2 (en) 2001-06-01 2002-12-12 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
CA2490409A1 (en) 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0730114B2 (ja) * 1985-04-03 1995-04-05 正雄 五十嵐 インヒビン
AU610821B2 (en) * 1985-04-18 1991-05-30 Inhibin Pty Limited Recombinant inhibin
AU5903986A (en) * 1985-04-18 1986-11-05 Biotechnology Australia Proprietary Limited Recombinant inhibin
NZ231899A (en) * 1985-10-03 1991-07-26 Genentech Inc Human or porcine inhibin peptide compositions and dna encoding them

Also Published As

Publication number Publication date
EP0232326B1 (de) 1994-10-05
US4740587A (en) 1988-04-26
AU6149886A (en) 1987-02-10
EP0232326A4 (de) 1988-06-14
EP0232326A1 (de) 1987-08-19
JPH07108916B2 (ja) 1995-11-22
JPS63500309A (ja) 1988-02-04
DE3650088T2 (de) 1995-01-26
DE3650088D1 (de) 1994-11-10
WO1987000528A1 (en) 1987-01-29
AU605105B2 (en) 1991-01-10

Similar Documents

Publication Publication Date Title
DE3650088D1 (de) Inhibin und dessen reinigung.
ATE113654T1 (de) Follistatin und verfahren zur reinigung desselben.
NO176570C (no) Proteinmateriale, inhibin, fremgangsmåte for renfremstilling av dette, antistoff mot inhibin, ikke-terapeutiske blandinger inneholdende inhibin/antistoff samt anvendelse for diagnostiske og analytiske formål
DE69033942D1 (de) Gliederstruktur für Gehroboter mit Beinen
EP0939121A3 (de) TFN-bindende Proteine
ATE125362T1 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
IE780912L (en) A glycoprotain and process for the production thereof
DE3877753D1 (de) Transformierender wachstumsfaktor-beta.
IL94039A0 (en) Antibodies to anti-cytotoxic proteins
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
ATE47155T1 (de) Monoklonaler antikoerper.
AU2275588A (en) Agents and procedures for provoking an immune response to gnrh and immuno sterilizing mammals
ATE57163T1 (de) Fahrzeughebebuehne.
AU567747B2 (en) Early detection of mammalian pregnancy
ES8505406A1 (es) Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
GB2083836A (en) Monoclonal antibody
DE3887750D1 (de) Selektive entfernung von immunkomplexen.
Pepys et al. An improved method for the isolation from Naja naja venom of cobra factor (CoF) free of phospholipase A
EP0109434A4 (de) In vitro diagnoseverfahren unter verwendung von monoklonalen antikörpern gegen konnektive gewebeproteine.
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
Nakamura et al. Physicochemical characterization of a PMN-derived soluble fraction that enhances lymphocyte DNA synthesis.
DK0383599T3 (da) Protein-anticancermiddel
Glant Concanavalin A-binding link protein in the proteoglycan aggregate of hyaline cartilage
FI971879A7 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käytt ö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
Masuho et al. Reconstruction of Intact γ-Globulin form S-Sulfonated γ-Globulin In Vivo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time